For: | Luo YJ, Huang QM, Ren Y, Liu ZL, Xu CF, Wang H, Xiao JW. Non-coding RNA in drug resistance of gastric cancer. World J Gastrointest Oncol 2019; 11(11): 957-970 [PMID: 31798777 DOI: 10.4251/wjgo.v11.i11.957] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i11/957.htm |
Number | Citing Articles |
1 |
Isaac Micallef, Byron Baron. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Non-Coding RNA 2021; 7(2): 24 doi: 10.3390/ncrna7020024
|
2 |
Guo-Hua Li, Qiang Qu, Ting-Ting Qi, Xin-Qi Teng, Hai-Hong Zhu, Jiao-Jiao Wang, Qiong Lu, Jian Qu. Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01974-y
|
3 |
Yajun Luo, Wanping Xiang, Zilin Liu, Lin Yao, Linghan Tang, Wang Tan, Pengcheng Ye, Jingyu Deng, Jiangwei Xiao. Functional role of the SLC7A11-AS1/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism. Free Radical Biology and Medicine 2022; 184: 53 doi: 10.1016/j.freeradbiomed.2022.03.026
|
4 |
Jizhao Wang, Yuchen Sun, Xing Zhang, Hui Cai, Cheng Zhang, Hangying Qu, Lin Liu, Mingxin Zhang, Junke Fu, Jia Zhang, Jiansheng Wang, Guangjian Zhang. Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p. Cell Death & Disease 2021; 12(1) doi: 10.1038/s41419-020-03368-y
|
5 |
Harshita Sharma, Divya Niveditha, Rajdeep Chowdhury, Sudeshna Mukherjee, Shibasish Chowdhury. A genome-wide expression profile of noncoding RNAs in human osteosarcoma cells as they acquire resistance to cisplatin. Discover Oncology 2021; 12(1) doi: 10.1007/s12672-021-00441-6
|
6 |
Fei Zhang, Mingliang Chu, Jiemin Liu, Qi Zhao, Yanqiu Zhu, Xuefang Wu. Shikonin Suppresses Cell Tumorigenesis in Gastric Cancer Associated
with the Inhibition of c-Myc and Yap-1. Combinatorial Chemistry & High Throughput Screening 2024; 27(13): 1919 doi: 10.2174/0113862073254088231020082912
|
7 |
Arefeh Zabeti Touchaei, Sogand Vahidi, Ali Akbar Samadani. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-023-01260-5
|
8 |
Qiang Zhang, Shuai Hu, Kai Zuo, Yunyun Guo, Lansheng Li. Nanoalbumin particles carrying microRNA-200c sensitize gastric cancer cells to cisplatin through targeting of phosphatase and tensin homolog (PTEN) gene. Materials Express 2022; 12(5): 691 doi: 10.1166/mex.2022.2199
|
9 |
Lubov Mitrofanova, Lubov Korneva, Igor Makarov, Maria Bortsova, Maria Sitnikova, Daria Ryzhkova, Dmitry Kudlay, Anna Starshinova. CD68-Negative Histiocytoses with Cardiac Involvement, Associated with COVID-19. International Journal of Molecular Sciences 2024; 25(18): 10086 doi: 10.3390/ijms251810086
|
10 |
Asal Jalal Abadi, Ali Zarrabi, Farid Hashemi, Amirhossein Zabolian, Masoud Najafi, Maliheh Entezari, Kiavash Hushmandi, Amir Reza Aref, Haroon Khan, Pooyan Makvandi, Saeed Ashrafizaveh, Tahereh Farkhondeh, Milad Ashrafizadeh, Saeed Samarghandian, Michael R. Hamblin. The role of SOX family transcription factors in gastric cancer. International Journal of Biological Macromolecules 2021; 180: 608 doi: 10.1016/j.ijbiomac.2021.02.202
|
11 |
Ling Lu, Bei Chen, Yumeng Xu, Xinyi Zhang, Longtao Jin, Hui Qian, Yi Wang, Zhao Feng Liang. Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.902302
|
12 |
Ying Zeng, Mei Ren, Yukun Li, Yanli Liu, Cong Chen, Jian Su, Bo Su, Hong Xia, Fang Liu, Hao Jiang, Hui Ling, Xi Zeng, Qi Su. Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway. Cancer Letters 2020; 492: 136 doi: 10.1016/j.canlet.2020.07.013
|
13 |
Maedeh Arabpour, Nima Rezaei. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_337-1
|
14 |
Zhifu Gui, Zhenguo Zhao, Qi Sun, Guoyi Shao, Jianming Huang, Wei Zhao, Yuting Kuang. LncRNA FEZF1-AS1 Promotes Multi-Drug Resistance of Gastric Cancer Cells via Upregulating ATG5. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.749129
|
15 |
Xiaofeng Wang, Rui He, Li Geng, Jing Yuan, Huijie Fan. Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.823182
|
16 |
Sayedeh Azimeh Hosseini, Mohammad Hossein Haddadi, Hadis Fathizadeh, Foroogh Nemati, Hooman Mahmoudi Aznaveh, Farima Taraj, AmirArsalan Aghabozorgizadeh, Golmaryam Gandomkar, Elaheh Bazazzadeh. Long non-coding RNAs and gastric cancer: An update of potential biomarkers and therapeutic applications. Biomedicine & Pharmacotherapy 2023; 163: 114407 doi: 10.1016/j.biopha.2023.114407
|
17 |
Zonglin Li, Xingming Shu, Xin Liu, Qiuyun Li, Yifu Hu, Bingbing Jia, Min Song. Cellular and Molecular Mechanisms of Chemoresistance for Gastric Cancer. International Journal of General Medicine 2024; : 3779 doi: 10.2147/IJGM.S473749
|
18 |
Ye Zhang, Xinxin Liu, Junying Zhang, Yuanyuan Xu, Jie Shao, Yue Hu, Peng Shu, Haibo Cheng. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway. Aging 2020; 12(7): 5640 doi: 10.18632/aging.102929
|